Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1882 1
1890 1
1893 2
1894 1
1900 1
1901 1
1904 1
1907 3
1908 1
1909 1
1912 1
1913 1
1914 1
1917 3
1921 1
1925 2
1926 1
1928 1
1931 1
1932 1
1950 1
1958 1
1963 1
1967 1
1968 3
1969 1
1970 1
1971 4
1972 4
1974 2
1975 4
1976 7
1977 4
1978 5
1979 5
1980 4
1981 1
1982 5
1983 3
1984 8
1985 10
1986 14
1987 6
1988 8
1989 10
1990 7
1991 5
1992 7
1993 10
1994 12
1995 8
1996 4
1997 9
1998 5
1999 6
2000 8
2001 11
2002 4
2003 5
2004 10
2005 14
2006 9
2007 11
2008 10
2009 12
2010 17
2011 13
2012 18
2013 8
2014 14
2015 18
2016 14
2017 18
2018 17
2019 24
2020 21
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

465 results
Results by year
Filters applied: . Clear all
Page 1
ESTRO-ACROP guideline "target delineation of glioblastomas".
Niyazi M, Brada M, Chalmers AJ, Combs SE, Erridge SC, Fiorentino A, Grosu AL, Lagerwaard FJ, Minniti G, Mirimanoff RO, Ricardi U, Short SC, Weber DC, Belka C. Niyazi M, et al. Among authors: chalmers aj. Radiother Oncol. 2016 Jan;118(1):35-42. doi: 10.1016/j.radonc.2015.12.003. Epub 2016 Jan 6. Radiother Oncol. 2016. PMID: 26777122
Glutamatergic synaptic input to glioma cells drives brain tumour progression.
Venkataramani V, Tanev DI, Strahle C, Studier-Fischer A, Fankhauser L, Kessler T, Körber C, Kardorff M, Ratliff M, Xie R, Horstmann H, Messer M, Paik SP, Knabbe J, Sahm F, Kurz FT, Acikgöz AA, Herrmannsdörfer F, Agarwal A, Bergles DE, Chalmers A, Miletic H, Turcan S, Mawrin C, Hänggi D, Liu HK, Wick W, Winkler F, Kuner T. Venkataramani V, et al. Among authors: chalmers a. Nature. 2019 Sep;573(7775):532-538. doi: 10.1038/s41586-019-1564-x. Epub 2019 Sep 18. Nature. 2019. PMID: 31534219
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial.
Palma DA, Olson R, Harrow S, Correa RJM, Schneiders F, Haasbeek CJA, Rodrigues GB, Lock M, Yaremko BP, Bauman GS, Ahmad B, Schellenberg D, Liu M, Gaede S, Laba J, Mulroy L, Senthi S, Louie AV, Swaminath A, Chalmers A, Warner A, Slotman BJ, de Gruijl TD, Allan A, Senan S. Palma DA, et al. Among authors: chalmers a. BMC Cancer. 2019 Aug 19;19(1):816. doi: 10.1186/s12885-019-5977-6. BMC Cancer. 2019. PMID: 31426760 Free PMC article. Clinical Trial.
Replication Stress Drives Constitutive Activation of the DNA Damage Response and Radioresistance in Glioblastoma Stem-like Cells.
Carruthers RD, Ahmed SU, Ramachandran S, Strathdee K, Kurian KM, Hedley A, Gomez-Roman N, Kalna G, Neilson M, Gilmour L, Stevenson KH, Hammond EM, Chalmers AJ. Carruthers RD, et al. Among authors: chalmers aj. Cancer Res. 2018 Sep 1;78(17):5060-5071. doi: 10.1158/0008-5472.CAN-18-0569. Epub 2018 Jul 5. Cancer Res. 2018. PMID: 29976574 Free PMC article.
Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.
Tardito S, Oudin A, Ahmed SU, Fack F, Keunen O, Zheng L, Miletic H, Sakariassen PØ, Weinstock A, Wagner A, Lindsay SL, Hock AK, Barnett SC, Ruppin E, Mørkve SH, Lund-Johansen M, Chalmers AJ, Bjerkvig R, Niclou SP, Gottlieb E. Tardito S, et al. Among authors: chalmers aj. Nat Cell Biol. 2015 Dec;17(12):1556-68. doi: 10.1038/ncb3272. Epub 2015 Nov 23. Nat Cell Biol. 2015. PMID: 26595383 Free PMC article.
Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death.
Ichim G, Lopez J, Ahmed SU, Muthalagu N, Giampazolias E, Delgado ME, Haller M, Riley JS, Mason SM, Athineos D, Parsons MJ, van de Kooij B, Bouchier-Hayes L, Chalmers AJ, Rooswinkel RW, Oberst A, Blyth K, Rehm M, Murphy DJ, Tait SWG. Ichim G, et al. Among authors: chalmers aj. Mol Cell. 2015 Mar 5;57(5):860-872. doi: 10.1016/j.molcel.2015.01.018. Epub 2015 Feb 19. Mol Cell. 2015. PMID: 25702873 Free PMC article.
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
Olson R, Mathews L, Liu M, Schellenberg D, Mou B, Berrang T, Harrow S, Correa RJM, Bhat V, Pai H, Mohamed I, Miller S, Schneiders F, Laba J, Wilke D, Senthi S, Louie AV, Swaminath A, Chalmers A, Gaede S, Warner A, de Gruijl TD, Allan A, Palma DA. Olson R, et al. Among authors: chalmers a. BMC Cancer. 2020 May 5;20(1):380. doi: 10.1186/s12885-020-06876-4. BMC Cancer. 2020. PMID: 32370765 Free PMC article.
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial.
Hanna C, Kurian KM, Williams K, Watts C, Jackson A, Carruthers R, Strathdee K, Cruickshank G, Dunn L, Erridge S, Godfrey L, Jefferies S, McBain C, Sleigh R, McCormick A, Pittman M, Halford S, Chalmers AJ. Hanna C, et al. Among authors: chalmers aj. Neuro Oncol. 2020 Dec 18;22(12):1840-1850. doi: 10.1093/neuonc/noaa104. Neuro Oncol. 2020. PMID: 32347934 Free PMC article. Clinical Trial.
Augmented Virtual Teleportation for High-Fidelity Telecollaboration.
Rhee T, Thompson S, Medeiros D, Dos Anjos R, Chalmers A. Rhee T, et al. Among authors: chalmers a. IEEE Trans Vis Comput Graph. 2020 May;26(5):1923-1933. doi: 10.1109/TVCG.2020.2973065. Epub 2020 Feb 13. IEEE Trans Vis Comput Graph. 2020. PMID: 32070972
465 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page